Oxazolone-Induced Delayed Type Hypersensitivity Reaction in the Adult Yucatan Pigs. A Useful Model for Drug Development and Validation

Por Nuhaily, Samer, Damaj, Bassam B., Maghazachi, Azzam A.
Publicado em 2009

Accelerating Drug Development Using Biomarkers: A Case Study with Sitagliptin, A Novel DPP4 Inhibitor for Type 2 Diabetes

Por Krishna, Rajesh, Herman, Gary, Wagner, John A.
Publicado em 2008

The evaluation of different types of anti-convulsant drug activity against leptazol-induced epileptogenic activity in the anaesthetized rat.

Por Kent, A. P., Webster, R. A.
Publicado em 1983

Development of drug resistance in a murine mammary tumour.

Por McMillan, T. J., Stephens, T. C., Steel, G. G.
Publicado em 1985

Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety

Por El-Nabarawi, Mohamed A., Tayel, Saadia A., Soliman, Nadia A., Abo Enin, Hadel A.
Publicado em 2013

Short Communication: A Repeated Simian Human Immunodeficiency Virus Reverse Transcriptase/Herpes...

Por Kenney, Jessica, Derby, Nina, Aravantinou, Meropi, Kleinbeck, Kyle, Frank, Ines, Gettie, Agegnehu, Grasperge, Brooke, Blanchard, James, Piatak, Michael, Lifson, Jeffrey D., Zydowsky, Thomas M., Robbiani, Melissa
Publicado em 2014

Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients

Por E. A. Kornienko
Publicado em 2019-07-01

Development of a Novel In Vitro Human Tissue-Based Angiogenesis Assay to Evaluate the Effect of Antiangiogenic Drugs

Por Woltering, Eugene A., Lewis, James M., Maxwell, P. Johnstone, Frey, Daniel J., Wang, Yi-Zarn, Rothermel, John, Anthony, Catherine T., Balster, Douglas A., O’Leary, J. Patrick, Harrison, Lynn H.
Publicado em 2003

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

Por Dou, Huanyu, Destache, Christopher J., Morehead, Justin R., Mosley, R. Lee, Boska, Michael D., Kingsley, Jeffrey, Gorantla, Santhi, Poluektova, Larisa, Nelson, Jay A., Chaubal, Mahesh, Werling, Jane, Kipp, James, Rabinow, Barrett E., Gendelman, Howard E.
Publicado em 2006

Possibilities of adaptive design implementation in clinical trials of next-in-class drugs

Por N. V. Vostokova, Yu. A. Trakhtenberg, E. A. Smolyarchuk, A. A. Svistunov
Publicado em 2018-02-01

Biochemical criteria of toxicity of therapy with high doses of methotrexate in children with osteosarcoma

Por A. M. Strizhevskaya, E. G. Golovnya, A. Z. Dzampaev, V. N. Baykova
Publicado em 2015-06-01

A Systemic Route for Drug Loading to Lymphatic Phagocytes

Por Papisov, M. I., Yurkovetskiy, A., Syed, S., Koshkina, N., Yin, M., Hiller, A., Fischman, A. J.
Publicado no Mol Pharm (2005)

Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials

Por Hansen, Aaron R., Cook, Natalie, Ricci, M. Stacey, Razak, Albiruni, Le Tourneau, Christophe, McKeever, Kathleen, Roskos, Lorin, Dixit, Rakesh, Siu, Lillian L., Hinrichs, Mary Jane
Publicado no Oncologist (2015)

Regenerating properties of new drug Dyalderon

Por M. A. Aziamov, T. V. Agalakova
Publicado em 2017-12-01

The non-medical use of antibiotics and the risk of causing microbial drug-resistance

Por Manten, A.
Publicado em 1963

Effect of Drug Concentration on Emergence of Macrolide Resistance in Mycobacterium avium

Por Nash, Kevin A.
Publicado em 2001

Development of a mobile application for vancomycin dosing calculation: A useful tool for the rational use of antimicrobials

Por Tácio de Mendonça Lima, Millena Padela da Silva, Luan Donato Silva Luz, Thais Cristina Amorim Estevão Soares, Etielle Silvestre Dantas, Gabriela Felix Teixeira, Rafael Henrique de Souza Costa, Sérgio Henrique Monte Santo Andrade
Publicado em 2022-03-01

Assessment of the Efficacy of New Anti-Tuberculosis Drugs

Por Mitchison, Denis A., Davies, Geraint R.
Publicado em 2008

Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates

Por Kamath, Amrita V., Iyer, Suhasini
Publicado no Pharm Res (2014)

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase...

Por Loemba, Hugues, Brenner, Bluma, Parniak, Michael A., Ma'ayan, Shlomo, Spira, Bonnie, Moisi, Daniela, Oliveira, Maureen, Detorio, Mervi, Wainberg, Mark A.
Publicado em 2002